Author: Jesse Landry

The Biological Computing Co. just pulled off something that sounds like science fiction until you realize Primary Ventures wired $25M to make it very real. In a world addicted to bigger GPUs and louder data centers, The Biological Computing Co. looked at silicon and said, that is cute. Alexander Ksendzovsky and Jonathan Pomeraniec, both neurosurgeon scientists, decided to build with the original processor. Neurons. Living ones. Not metaphors. Not marketing. Actual biological networks encoding images and video, decoding neural activity into representations that plug directly into state of the art AI models. This is a San Francisco outfit, Mission Bay…

Read More

There is a difference between knowing your numbers and knowing your work. Most companies can tell you revenue to the penny. Ask them how the work actually flows through the building and you get silence. That gap is where Reflow lives. Reflow, founded in 2024 and based in San Francisco, just launched with $15M+ in seed funding to make enterprise operations observable at scale. The round is backed by e2vc, Basis Set Ventures, Bling Capital, Better Tomorrow Ventures, and Designer Fund. Smart capital betting on clarity in a world drunk on dashboards. Founder Uğur Kaner has been here before. As…

Read More

Consensys has always moved like the quiet architect on a loud block, the kind of company that ignores the noise and pours concrete while everyone else argues about paint colors. In a market addicted to price charts and dopamine spikes, Consensys kept its head down, wiring Ethereum into something functional, repeatable, and durable. Founded in Brooklyn by Joseph Lubin, co-founder of Ethereum and still Founder and CEO, the company was built to serve the plumbing of the internet’s next phase, not its hype cycles. That posture has made Consensys less flashy than most and far harder to replace inside the…

Read More

Founder Collective does not posture. It does not chase noise. It writes the first check when conviction outweighs consensus, and that discipline has made it one of the most influential seed investors inside the modern startup ecosystem. Many of the companies it backed at inception are now category leaders, and a meaningful number of them are hiring as they scale. The firm was co-founded by David Frankel and Eric Paley, both repeat entrepreneurs before they ever deployed institutional capital. David Frankel built Internet Solutions into one of Africa’s largest internet service providers before its acquisition by Dimension Data. Eric Paley…

Read More

C1 Fund Inc. does not posture. It documents. On February 4, 2026, the company disclosed that its Board of Directors authorized a share repurchase program of up to $3M. No executive quotes. No narrative scaffolding. Just authorization, mechanics, and time horizon. Open market purchases through FINRA registered broker dealers, running through December 31, 2027 unless extended. In the world of startup news, silence like this is rarely accidental. The language is restrained because the intent is precise. The Board, unnamed and collective, frames the program as optional, not promised. Shares may be repurchased below NAV, which the release notes could…

Read More

Santé just raised $7.6M in seed capital, and if you have ever stepped behind the counter of a neighborhood liquor store, you already know why that matters. Liquor retail looks simple from the sidewalk. Bottles on shelves. A bell on the door. But behind that counter it is organized chaos. Break pack pricing. Vintages. Case splits. State by state regulation that reads like a Shakespearean tragedy. Darren Fike saw it up close, worked the floor, interviewed more than 100 owners, and decided the industry deserved better than pen, paper, and point of sale systems old enough to rent a car.…

Read More

There is a special kind of irony in healthcare. The people trained to save lives end up fighting faxes. Abdel Mahmoud, M.D., Founder & CEO, saw it inside the UK National Health Service. Physician. Computer scientist. Sandhurst graduate. Former British Army infantry officer. Later, product leader at Meta and Google. In 2022, he co-founded Co:Helm with Zahid Mahmood, Founder & CTO, an engineer from UCL and Queen Mary University who built and exited Berryness and worked in insurance automation at Global Aerospace. They joined Sequoia Capital’s Arc program, raised a $3.2M seed led by Sequoia with Blue Lion Global, Anamcara…

Read More

There is something poetic about a company named Ever choosing a category most people treat like a one time headache. Buying and selling cars has always felt temporary. Paperwork. Negotiation. A handshake you hope you can trust. Ever Cars Co. looked at a $1.2T U.S. auto retail market, the largest slice of the retail economy, and said this should feel different. Not once. Not occasionally. Ever. Out of San Francisco, operating at evercars.com, this AI native, full stack auto retail company focused on used EVs just stepped out of stealth with a $31M oversubscribed Series A led by Eclipse. Total…

Read More

Project Omega just stepped out of stealth with $12M in seed capital, and if you listen closely you can hear 90,000+ metric tons of spent nuclear fuel clearing its throat. This round was led by Starship Ventures, with Mantis Ventures, Buckley Ventures, Decisive Point, Slow Ventures and others leaning in. Not a tourist list. A conviction list. The kind of cap table that says, “Yes, we read the footnotes.” Omega Project Co., incorporated in Texas and operating out of Rhode Island, is not chasing vibes. It is rebuilding the nuclear fuel cycle end to end and turning yesterday’s liability into…

Read More

There is a certain kind of founder story that does not start in a boardroom. It starts at 3 a.m., staring at the ceiling, bargaining with sleep like it is a stubborn landlord. Peter Hames lived that loop. Chronic insomnia. A prescription pad offered as the grand solution. Instead, Peter Hames found Cognitive Behavioral Therapy in Professor Colin Espie’s work, ran the protocol himself, and walked out the other side. In 2010, Big Health was born in San Francisco with a simple premise: if evidence works, scale it. Fast forward to February 11, 2026. Big Health just secured $23.7M in…

Read More